NEPH — Nephros Cashflow Statement
0.000.00%
Last trade - 00:00
- $21.09m
- $16.78m
- $14.24m
- 65
- 39
- 82
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.18 | -4.53 | -3.87 | -7.11 | -1.57 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.28 | 0.908 | 1.31 | 3.29 | 1.02 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.58 | -3.49 | 0.883 | 0.229 | 1.17 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -2.28 | -6.9 | -1.42 | -3.23 | 0.827 |
Capital Expenditures | -0.014 | -0.239 | -0.036 | -0.137 | -0.075 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.137 | 0 | -0.049 | 0 | — |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.151 | -0.239 | -0.085 | -0.137 | -0.075 |
Financing Cash Flow Items | -0.082 | -0.085 | 0 | -0.031 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.02 | 11.2 | 0.237 | 0.034 | -0.079 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.415 | 4.08 | -1.28 | -3.34 | 0.673 |